News & Updates

Daily supplementation with multivitamins offers no significant protection against the incidence of COVID-19 in older adults when compared with placebo, as shown in the COSMOS randomized trial.

A 156-week safety extension study presented at EAN 2026 shows the first 3-year long-term results for atogepant in the preventive treatment of migraine in individuals with chronic migraine (CM) or episodic migraine (EM) who had an insufficient response to 2–4 classes of conventional oral, non-migraine-specific preventive migraine treatments.

Results from the GIraFFE* study shed light on the potential protective effect of whole goat milk formula (WGF) against the development of atopic dermatitis (AD) in infants, compared with cow milk formula (CF).